Drug Trial Radar · NCT01119105
Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Last checked: Nov 19, 2026Latest source record: Nov 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
210
Actual
Start
May 2010
Primary completion
Dec 31, 2010
Study completion Feb 3, 2011
Sponsor
- Lead sponsor
- Nabriva Therapeutics AGIndustry
- Sponsor type
- Industry
- First posted
- May 7, 2010
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase II, multi-center, randomized, double-blind study comparing the safety and efficacy of two doses of BC-3781 versus vancomycin in patients with acute bacterial skin and skin structure infection.
Conditions
- Bacterial Infections
- Infection
Interventions
BC-3781Drug
BC-3781 dose 100mg is administered as i.v. infusion every 12 h for 5 to 14 days depending on the clinical response.
BC-3781Drug
BC-3781 dose 150mg is administered as i.v. infusion every 12 h for 5 to 14 days depending on the clinical response.
VancomycinDrug
Vancomycin is administered as i.v. infusion every 12 h for 5 to 14 days depending on the clinical response.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical ResponseTime frame: Test of Cure (TOC), 7 - 14 days post final treatment
- Clinical ResponseTime frame: Test of Cure (TOC), 7 - 14 days post final treatment
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
BC-3781 Study Center 002
Chula Vista, California
BC-3781 Study Center 001
La Mesa, California
BC-3781 Study Center 003
Oceanside, California
BC-3781 Study Center 012
Columbus, Georgia
BC-3781 Study Center 018
Savannah, Georgia
BC-3781 Study Center 021
Baton Rouge, Louisiana
BC-3781 Study Center 023
Lafayette, Louisiana
BC-3781 Study Center 004
Butte, Montana
BC-3781 Study Center 016
Somers Point, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.